INTRODUCTION
A cough is a sudden and forceful expiration of air from the lungs caused by an involuntary contraction of the muscles controlling the process of breathing. It is a protective reflex that removes foreign material and secretions from the bronchi and bronchioles. The cough reflex consists of four phases: Inhalation, Compression of air against a closed glottis, Expression, Relaxation. 1 It can be inappropriately stimulated by inflammation of the respiratory tract or by neoplasia. In these cases, anti-tussive or cough suppressant drugs are used. 2 For uncontrolled cough, opioidergic central cough suppressants are used. Among opioids, codeine, pholcodeine, noscapine, dextromethorphan are effective, but they have certain inherent side effects like sedation, constipation, and also some addiction liability. 3 Therefore, there is need to have effective anti-tussive drug which can successfully alleviate chronic cough without any contraindication & side effects. Vasu Cough Syrup is one such Ayurvedic formulation containing herbal ingredients like Extract of Glycyrrhiza glabra (Yashtimadhu) 1, 4, 5 , Ocimum sanctum (Tulsi) 6 , Terminalia belerica (Bibhitaki) 7 , Adhatoda vasica (Vasa) 1, 8 , Solanum xanthocarpum (Kantakari) 9 , Zingiber officinale (Shunthi) 10 , Curcuma longa (Haridra) 11, 12 ,Trikatu
13
. Literature search for each of these ingredients have showed promising anti-tussive activity but no scientific evidence was available for overall anti-tussive action of combination of such herbs. Hence, the present study was aimed to evaluate anti-tussive activity of Vasu Cough Syrup in sulphur dioxide (SO 2 ) induced cough model in mice along with acute oral toxicity.
MATERIALS AND METHODS

Drugs and chemicals
Solvents and chemicals required for the investigations are Vasu Cough Syrup, distilled water, codeine phosphate, sodium hydrogen sulfite (NaHSO 3 ), sulphuric acid (H 2 SO 4 ).
All chemicals were of analytical grade. Vasu Cough Syrup was procured from Vasu Healthcare Pvt Ltd Vadodara, India.
Experimental animals
The experiments were performed on male albino mice weighing between 25-30 g. Mice were grouped and housed in polyacrylic cages (38x23x10 cm) with not more than six animals per cage and maintained under standard laboratory conditions with natural dark and light cycle. They were allowed free access to standard dry rodent diet (Golden Feeds, India) and tap water ad libitum. Food and water were withheld only during experimentation. After acclimatization, mice were randomly divided into four groups. Each group comprised of 6 animals. All experimental procedures described were reviewed and approved by the Institutional Animal Ethics Committee. All the experimental protocols were approved by the Institutional Animal Ethics Committee (IAEC), Sigma Institute of Pharmacy (SIP/IAEC/02/2012-13). All the experiments and the care of the laboratory animals were according to current ethical guidelines by the Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA), Ministry of Environment and Forests, Government of India, New Delhi. Acute oral toxicity study The acute toxicity study was carried out as per the guidelines set by Organization for Economic Co-operation and Development (OECD), revised draft guidelines no. 423, received from Committee for the purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Social Justice and Empowerment, Govt. of India.
14 Evaluation of anti-tussive activity of polyherbal formulation in Sulphur dioxide (SO 2 ) induced cough model in mice 15 For evaluation of anti-tussive activity method of Miyagoshi et al., 1986 was modified and simplified to use. Briefly, a vial containing 2 mL of 500mg/mL solution of sodium hydrogen sulfite (NaHSO 3 ) in double distilled water was placed at the base of a dessicator and covered with wire gauze to serve as a platform for placement of mice. To the NaHSO 3 solution, 0.2 mL of sulphuric acid (H 2 SO 4 ), was added using a pipette. The reaction involved is as follows: 2NaHSO 3 + H 2 SO 4 2SO 2 + Na2SO 4 + H 2 O After 15 seconds, the mice were placed on the platform in the dessicator and exposed to SO2 for 30 seconds. The mice were then removed from the dessicator and placed in an observation chamber for counting of bouts of cough for five minutes thereafter.
Scoring of bouts of cough
To avoid the observer bias, cough bouts were independently counted by two observers using digital counters and stopwatches. If for any reading the difference in count among observers was more than 10%, the experiment was discarded. Readings are mean of these two observations.
Grouping & Drug treatment
All drugs were administered orally. The mice were divided into four groups of six animals each. Group-I served as Disease control and was not administered anything. Group-II received standard drug i.e. Codeine phosphate (10 mg/kg), p.o., Group-III to IV were given Vasu Cough Syrup 0.25mL/kg and 0.5mL/kg dose respectively. Each animal served as its own control and was exposed to Sulphur dioxide twice i.e. Before and 30 minutes after drug treatment. Grouping and drug treatment detail was tabulated in Table 1 .
Statistical Analysis:
The results are expressed as mean values ± S.E.M. (standard error of mean). The significance was evaluated by one way ANOVA, followed by Tukey's multiple comparison test. The results were considered statistically significant when P < 0.05. 
RESULTS & DISCUSSION Acute oral toxicity study of Vasu Cough Syrup
During the acute oral toxicity study, the animals did not show any signs of toxicity and mortality at 2000 mg/kg single dose administration of Vasu Cough Syrup. The body weight was not significantly increased or decreased ( Table 2) .
Evaluation of anti-tussive activity of Vasu Cough Syrup in Sulphur dioxide (SO 2 ) induced cough model in mice
In Disease controls, there was no significant change in the number of cough bouts, between the two exposures. The effect of the Vasu Cough Syrup on SO 2 gas induced cough in experimental animals showed significant cough suppressant effects at both the dose levels in comparison to disease control. Vasu Cough Syrup showed 63.91% and 70.64% inhibition in frequency of cough at 0.25mL/kg and 0.5mL/kg dose level respectively. The Codeine phosphate used as a standard drug for suppression of cough showed 79.35% inhibition in frequency of cough at a dose of 10 mg/kg. Vasu Cough Syrup at 0.5mL/kg dose level showed comparative effect like standard drug, Codeine phosphate (Table 3) . 
CONCLUSION
